Vimian Group AB (publ) (OTCMKTS:VIMGF – Get Free Report) shares traded down 35.6% during trading on Wednesday . The stock traded as low as C$2.77 and last traded at C$2.77. 569 shares traded hands during trading, a decline of 86% from the average session volume of 4,080 shares. The stock had previously closed at C$4.30.
Vimian Group AB (publ) Stock Performance
The firm has a 50-day moving average price of C$3.01 and a 200 day moving average price of C$3.66.
Vimian Group AB (publ) Company Profile
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name.
See Also
- Five stocks we like better than Vimian Group AB (publ)
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport
- 3 Fintech Stocks With Good 2021 Prospects
- Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock
- Expert Stock Trading Psychology Tips
- Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish
Receive News & Ratings for Vimian Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vimian Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
